MoneyWorks4Me

Procter&Gamble Healt - Quaterly Results

02 May 2024 Evaluate
The sales declined to Rs. 2524.80 millions for the March 2024 quarter as compared to Rs. 3209.20 millions during the corresponding quarter last year.The Net Profit of the company registered a slight decline of -21.34% to Rs. 465.60  millions from Rs. 591.90 millions.A decline of 697.10 millions was observed in the OP in the quarter ended March 2024 from 846.30 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202306 202206 % Var
Sales 2524.80 3209.20 -21.33 8673.80 9284.40 -6.58 12296.20 11144.10 10.34
Other Income 22.70 49.70 -54.33 135.00 129.30 4.41 183.90 131.90 39.42
PBIDT 697.10 846.30 -17.63 2712.50 2922.70 -7.19 3430.70 2808.70 22.15
Interest 1.50 2.10 -28.57 5.20 6.00 -13.33 7.70 4.20 83.33
PBDT 695.60 844.20 -17.60 2707.30 2916.70 -7.18 3423.00 2804.50 22.05
Depreciation 68.40 58.90 16.13 202.40 216.00 -6.30 281.00 270.80 3.77
PBT 627.20 785.30 -20.13 2504.90 2700.70 -7.25 3142.00 2533.70 24.01
TAX 161.60 193.40 -16.44 662.90 704.20 -5.86 847.30 608.50 39.24
Deferred Tax -1.40 -33.70 -95.85 -18.60 -42.60 -56.34 -50.60 0.40 -12750.00
PAT 465.60 591.90 -21.34 1842.00 1996.50 -7.74 2294.70 1925.20 19.19
Equity 166.00 166.00 0.00 166.00 166.00 0.00 166.00 166.00 0.00
PBIDTM(%) 27.61 26.37 4.70 31.27 31.48 -0.66 27.90 25.20 10.70
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..